Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Clissold S. P., Campoli-Richards D. M. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs. 1986 Jul;32(1):15–47. doi: 10.2165/00003495-198632010-00002. [DOI] [PubMed] [Google Scholar]
- Haley T. J. Disulfiram (tetraethylthioperoxydicarbonic diamide): a reappraisal of its toxicity and therapeutic application. Drug Metab Rev. 1979;9(2):319–335. doi: 10.3109/03602537908993897. [DOI] [PubMed] [Google Scholar]
- Lagerström P. O., Persson B. A. Determination of omeprazole and metabolites in plasma and urine by liquid chromatography. J Chromatogr. 1984 Aug 10;309(2):347–356. doi: 10.1016/0378-4347(84)80042-0. [DOI] [PubMed] [Google Scholar]
- Peachey J. E., Brien J. F., Roach C. A., Loomis C. W. A comparative review of the pharmacological and toxicological properties of disulfiram and calcium carbimide. J Clin Psychopharmacol. 1981 Jan;1(1):21–26. doi: 10.1097/00004714-198101000-00005. [DOI] [PubMed] [Google Scholar]
- Renberg L., Simonsson R., Hoffmann K. J. Identification of two main urinary metabolites of [14C]omeprazole in humans. Drug Metab Dispos. 1989 Jan-Feb;17(1):69–76. [PubMed] [Google Scholar]
